A novel group of Stat3 pathway inhibitors and cancer stem cell pathway inhibitors

摘要

PROBLEM TO BE SOLVED: To provide a Stat3 pathway inhibitor for treating a condition. The present invention uses a novel class of cancer stem cell pathway (CSPP) inhibitor; treatment-resistant, recurrent or metastatic. How to use such compounds to treat cancer; how to use such compounds in specific dosing regimens to selectively kill cancer cells; how to target cancer stem cells by inhibiting the Stat3 pathway How to use novel compounds in the treatment of mammalian conditions or disorders associated with abnormal Stat3 pathway activity; and how to prepare such compounds and their intermediates, as well as pharmaceutical compositions of related compounds, and compounds thereof. Regarding the specific administration method of. [Selection diagram] None